Not so fast!

Sanofi announced today that the Auvi-Q is finally available in the United States.  This is exciting news in the food allergy world.  This new device is full of promise with it’s much smaller size, less intimidating shape, and voice-guided instructions.  For teens and adults, it is great to have another choice, but  I am concerned about the children that must rely on others to administer the epinephrine. As a former teacher I always think of the implications in a school setting.  Although, the Auvi-Q is voice-guided I still believe it is imperative that anyone responsibile for my child be comfortable with using it BEFORE a reaction occurs. 

So, here’s what I would like to know:

  • How will schools effectively respond to having 1, 2 or even 3 different devices when training?  (It has been difficult enough to ensure that the appropriate people are trained with only one device. )
  • How long will it take for parents, caregivers, teachers and others to become comfortable with a new device?
  • Will voice-guided instructions help people to be more comfortable using the device?
  • Will voice-guided instructions impact how effectively the epinephrine is administered?

While I admit that I am excited to meet the “new kid on the block”, I also acknowledge the fact that there will be a learning curve here and that it will be important to advocate for training using all devices.  

What do you think?  Will you try the new Auvi-Q?



Gina Mennett Lee, M.Ed.

President and Founder, Food Allergy Education Network

Leave a Reply

Your email address will not be published.